genprowebdirectory
GEN Edge
News
Insights
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
GEN Edge
Assessing Coronavirus Impact on Wall Street
GEN Edge
At Laboratory for Advanced Medicine, New CEO Sharpens Commercial Focus
GEN Edge
Regeneron Hits the Accelerator
GEN Edge
Global Blood Therapeutics CEO Defends Price of Sickle-Cell Drug Oxbryta
GEN Edge
Trial Triumphs, Takeover Talk Boost Reata Pharmaceuticals
News
News
Soothing Eczema by Riling Natural Killer Cells
News
MGI Delivers the $100 Genome at AGBT Conference
Genetics
New Biological Mechanism of Insulin Signaling Discovered
News
Microbiome’s Missing Bacteria Linked with Ulcerative Colitis
News
CRISPR Too Much of a Good Thing for Some Bacterial Species
Insights
All
Trends for 2020
Cell Therapy
More Cell and Gene Therapy Facilities in the Hundreds are Needed
Bioprocessing
Titer Testing by Design
Insights
The Vertex Method’s Success Story
Commentary
Translating Pharmacomicrobiomics: Three Actionable Challenges/Prospects in 2020
A-Lists
Insights
Top 10 Life Sciences Jobs Most in Demand over the Next…
GEN Edge
Ten Life Science Analysts to Watch in 2020
Insights
Top 10 Young Companies in the Money, 2019
January 2020 Vol. 40 No. 1
8 Biopharma Trends to Watch in 2020
Cancer
Top 10 Immuno-Oncology Startups of 2019
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
News
Soothing Eczema by Riling Natural Killer Cells
News
MGI Delivers the $100 Genome at AGBT Conference
News
Microbiome’s Missing Bacteria Linked with Ulcerative Colitis
Cell Therapy
More Cell and Gene Therapy Facilities in the Hundreds are Needed
Magazine
February 2020 Vol. 40 No. 2
Building SynBio Platforms to Support Practical Apps
February 2020 Vol. 40 No. 2
Phage Therapy May Combine Efficacy and Convenience
February 2020 Vol. 40 No. 2
Guilty as Charged
February 2020 Vol. 40 No. 2
Gene Therapy Dollar Is Waiting on Viral Vector Dime
February 2020 Vol. 40 No. 2
Antibody Screening Technology Is Never Out of Sorts
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Upcoming Webinars
The Successful Evolution of Biotherapies from Discovery to Development
February 2020 Vol. 40 No. 2
A Small-Footprint, Integrated, and Automated Platform for Viral Production
Drug Discovery
Assessing Phenotypic Changes in Zebrafish through Automated Quantitative Imaging
10x Genomics
Bridging Genomics and Tissue Pathology
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Liver Diseases
Liver Diseases
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Liver Diseases
Boehringer Ingelheim, Enleofen Ink $1B-Per-Product Anti-IL-11 Partnership Focused on NASH, Lung Disorders
Liver Diseases
Type 2 Diabetes Triggered by Overspill of Fat from Liver into Pancreas
Liver Diseases
Dicerna, Novo Nordisk Eye 30+ Liver Targets in Up-to-$3.8B RNAi Partnership
Liver Diseases
Xenotransplant Developer eGenesis Raises $100M in Series B Financing
Liver Diseases
Pfizer to Develop Akcea/Ionis Antisense Candidate for Up to $1.5B
Liver Diseases
Lab-Grown Engineered Human Mini Livers Offer New Insights into NAFLD Drug...
Liver Diseases
Enzyme Associated with Detoxification Linked to Obesity and Fatty Liver Disease
Liver Diseases
Single-Cell RNA Seq Creates Human Liver Cell Atlas
Liver Diseases
Boehringer Ingelheim, Yuhan Launch Up-to-$870M+ NASH Collaboration
Liver Diseases
PROTACs Developed with U. of Dundee Boost Boehringer Ingelheim’s Cancer Pipeline
Liver Diseases
Genentech, Parvus Therapeutics Launch Up-to-$800M Autoimmune Collaboration
Liver Diseases
Gilead Sciences, insitro Launch Up-to-$1B+ AI-Based NASH Drug Collaboration
Liver Diseases
Alnylam, Regeneron Launch $1B RNAi Collaboration Focused on Eye, CNS, Liver...
Liver Diseases
Pfizer Gains Option to Buy Rare Disease Gene Therapy Developer Vivet...
Liver Diseases
Gilead’s Lead Liver Disease Candidate Selonsertib Fails Phase III Trial in...
Load more
Scroll Up
Please wait while you are redirected to the right page...
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
